Feedback / Questions
CNTO6785 - J&J, Fontacea
JNJ: Pharmaceutical Business Review
(J&J)
-
May 23, 2015 -
Anticipated regulatory filing for COPD during 2020-2024
Anticipated regulatory
•
Chronic Obstructive Pulmonary Disease
http://www.investor.jnj.com/webcasts-presentations.cfm
May 23, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.